# ZILRETTA
> **NDA208845** · New Drug Application · Sponsor: PACIRA PHARMS INC · Approved 2017-10-06
## Drug
- **FDA Application Number:** NDA208845
- **Application type:** New Drug Application
- **Brand name:** ZILRETTA
- **Generic name:** TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION
- **Active ingredients:** TRIAMCINOLONE ACETONIDE
- **Dosage form:** FOR SUSPENSION, EXTENDED RELEASE
- **Route:** INTRA-ARTICULAR
- **Marketing status:** Prescription
- **Sponsor:** PACIRA PHARMS INC
- **Manufacturer:** Pacira Pharmaceuticals, Inc.
- **First approval:** 2017-10-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208845)
---
*MORVS · CC0 1.0*